IL-1 Pathway May Stop Candida Fungus from Turning Fatal in Weakened Immunity

Researchers at King's College London have discovered an immune pathway that prevents Candida albicans, a normally harmless fungus, from developing into a life-threatening infection. Published in Nature Microbiology, this groundbreaking study explains why only certain patients with compromised immune systems—including those undergoing chemotherapy or living with HIV—develop severe candida infections. This discovery could lead to new therapeutic strategies to protect vulnerable populations from fatal fungal infections. Understanding the IL-1 pathway's protective role opens new avenues for treatment development and could significantly improve outcomes for immunocompromised patients.